From a pharmacological safety perspective, the adverse effect profile of retatrutide based on Phase 1 and Phase 2 clinical trial data (including the NEJM 2023 Phase 2 trial) includes: Gastrointestinal effects: Nausea, vomiting, diarrhoea, and constipation (the most commonly reported side effects in trial participants) Injection site reactions: Redness, swelling, or discomfort at the injection site Cardiovascular effects: Increases in heart rate have been observed in trial participants [21] [22] Hypoglycaemia: Particularly relevant in individuals with diabetes or those taking insulin, sulfonylureas, or other glucose-lowering agents Potential thyroid effects: GLP-1 receptor agonists have been associated with thyroid C-cell changes in rodent studies
Traceable via CAS 137525-51-0, CAS 77591-33-4, and CAS 89030-95-5, the blend supports transparent documentation and EU-aligned research compliance
Who Can Benefit from B Complex Injections
Recycles Other Antioxidants: Glutathione can help your body recycle vitamin C and vitamin E for better results in your IV antioxidant therapy
A: The population of Medicaid recipients attributed to the PPS constitutes the measurement population
